Table 1.
Host | Common Name of Virus, Subgenus, Genus | Receptor/s | Clinical Manifestation/s | Vaccine Strategies | References |
---|---|---|---|---|---|
Humans | SARS-CoV-2, Sarbecovirus, Betacoronavirus |
ACE2 | Fever, cough, atypical pneumonia, acute respiratory distress syndrome, diarrhea, and multiple organ failure | Viral-vectored; mRNA-based; DNA-based; live attenuated; inactivated, protein subunit; virus-like particle | [9,10,29] |
Cattle | Bovine coronavirus (BCoV), Embecovirus, Betacoronavirus | Neu5,9Ac2/ HLA-I | Diarrhea, winter dysentery, and/or respiratory disease | Live attenuated; inactivated |
[20,29,30,31] |
Pigs | Transmissible gastroenteritis virus (TGEV), Tegacovirus, Alphacoronavirus |
APN | Diarrhea, vomiting | Live attenuated; inactivated; recombinant proteins expressed in baculovirus, yeast, and plants; DNA-based | [18,19,20,29,30,32] |
Porcine respiratory coronavirus (PRCoV), Tegacovirus, Alphacoronavirus |
APN | Fever, atypical pneumonia | Recombinant adenovirus vector-based | [19,20,29,33] | |
Porcine epidemic diarrhea virus (PEDV), Pedacovirus, Alphacoronavirus |
Sialic acid? APN 1 |
Diarrhea, vomiting | Live attenuated; inactivated; recombinant proteins expressed in baculovirus, yeast, plants and bacteria; DNA-based | [18,19,29,30,32] | |
Swine acute diarrhea syndrome coronavirus (SADS-CoV)/Swine enteric alphacoronavirus (SeACoV), Rhinacovirus, Alphacoronavirus |
Not determined | Diarrhea, vomiting | Inactivated (reported as unpublished data in Zhou et al. (2019) [34]) | [18,29,34,35] | |
Porcine deltacoronavirus (PDCoV), Buldecovirus, Deltacoronavirus |
APN, other unknown receptor/s? | Diarrhea, vomiting | Inactivated | [18,29,36] | |
Porcine hemagglutinating encephalomyelitis virus (PHEV), Embecovirus, Betacoronavirus |
Neu5,9Ac2 | Neurological signs, vomiting, wasting | Inactivated and DNA-based vaccine evaluated in mice | [29,37,38] | |
Poultry | Infectious bronchitis virus (IBV) Igacovirus, Gammacoronavirus |
Neu5Gc | Respiratory disease, renal injury, and/or reduction in egg quality and quantity | Live attenuated; inactivated; viral vector-based; subunit/peptide-based; plasmid DNA-based | [21,22,29,39,40] |
Cats | Feline coronavirus I (FCoV-I), Feline coronavirus II (FCoV-II), Tegacovirus, Alphacoronavirus |
APN | Mild diarrhea, asymptomatic infection (feline enteric CoV (FECoV)). Body cavity effusions and fibrinous and/or granulomatous inflammatory lesions in various organs (seen in wet form of feline infectious peritonitis virus (FIPV)). Uveitis and neurological signs (common in dry form of FIPV). | Modified live intranasal vaccine (was licensed, but not recommended by American Association of Feline Practitioners). | [17,29,41] |
Dogs | Canine coronavirus I (CCoV-I), Canine coronavirus II (CCoV-II), Tegacovirus, Alphacoronavirus |
APN | Mild diarrhea. Systemic disease with vomiting, hemorrhagic diarrhea, and neurologic signs (pantropic CCoV-II) |
Modified live; inactivated | [14,29,30] |
Canine respiratory coronavirus (CRCoV), Embecovirus, Betacoronavirus |
HLA-I | Mild respiratory disease | No information available | [14,29,42] |
1 It has been demonstrated that APN is not a functional receptor of PEDV [18].